The present invention refers to a liquid composition comprising Vitamin C, L-glutamine and/or L-glutamic acid, L-cysteine and/or L-cystine, riboflavin, succinic acid, fumaric acid, coenzyme Q 10, niacin and hydrogen carbonate, phosphate or any other buffering system, in particular for use as a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The present invention refers further to the composition according to the invention for use in the treatment and/or prophylaxis of neuropathy, neurodegenerative diseases including late-onset Alzheimer′s disease, tumour metastasis and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer.本發明關於包含維生素C、L-麩醯胺酸和/或L-谷氨酸、L-半胱氨酸和/或L-胱氨酸、核黃素、琥珀酸、富馬酸、輔酶Q10、菸鹼酸和碳酸氫鹽、磷酸鹽或任何其他緩衝體系的液體組合物,特別地分別作為食品組合物、飲食或食品補充劑、和藥物組合物使用。本發明進一步關於在治療和/或預防神經病、神經變性性疾病,包括遲發性阿茲海默症、腫瘤轉移和癌症,特別是胰腺、食管、口咽喉、肝、結腸直腸、肺和/或乳腺癌中使用的依照本發明的組合物。
